Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
London pre-open: Stocks set to rise on return from Christmas
(Sharecast News) - London's stock market was looking at a positive return from the Christmas break on Wednesday, even as concern around China's skyrocketing Covid-19 case numbers continued. The FTSE 100 was expected to open 35 points higher, having closed up 0.05% at 7,473.01 on its last trading day, 23 December.
"US and European futures are trading in a narrow range while trading volume continues to remain on the low side," said AvaTrade chief market analyst Naeem Aslam.
"Yesterday, we did see the US stock indices recording small gains, but the percentage gains in the US stock indices were still on the low side and hardly exciting enough to attract new capital.
"Investors are enthusiastic about China re-opening its economy.
"However, there are plenty of reports which suggest that Covid cases are on the rise in China, which really threatens the supply chain."
It was looking to be a quiet day on the economic calendar, as expected, although the Richmond Manufacturing Index and pending home sales data was due out stateside at 1500 GMT.
Economists were expecting prints of -10 and -0.9%, respectively.
"When it comes to the housing data, it is pretty clear that the housing market is prone to a lot of risk and weakness going into 2023 as the Fed continues to embark on its hawkish monetary policy," Naeem Aslam added.
"The Fed has already increased the interest rate a number of times, and it is widely anticipated that the Fed is unlikely to take its foot off the gas paddle next year as well.
"This means that the housing market in the US is most likely to slow down even further, and we will see the housing market producing even more horrible numbers in 2023."
Stocks were in a mixed state at the closing bell on Wall Street on Tuesday, with the Dow Jones Industrial Average up 0.11% at 33,241.56.
The S&P 500, meanwhile, fell 0.4% to 3,829.25, and the Nasdaq Composite slid 1.38% to 10,353.23.
On London's equity markets, AstraZeneca's immunotherapies Imfinzi and Imjudo have been approved in Japan for the treatment of three cancer types - advanced liver, biliary tract and lung.
The FTSE 100 pharmaceuticals giant said the approvals would authorise Imfinzi in combination with Imjudo for the treatment of adult patients with unresectable hepatocellular carcinoma (HCC) and for the treatment of adult patients with unresectable, advanced or recurrent non-small cell lung cancer (NSCLC) in combination with chemotherapy.
Imfinzi was also authorised for the treatment of adult patients with unresectable HCC as monotherapy and for the treatment of adult patients with curatively unresectable biliary tract cancer (BTC) in combination with chemotherapy.
Elsewhere, Fresnillo confirmed that the final testing of the downstream power distribution and control systems at the Juanicipio project was now complete.
The FTSE 100 company said that concluded the additional testing requested by the state-owned power company, CFE, to verify compatibility between new and updated substation equipment installed by Fresnillo on behalf of Fresnillo and MAG Silver.
As such, the entire system had now been energised, and commissioning of the project had formally started.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.